Neurological Complications of Ebola Virus Infection

Neurotherapeutics

Volumn 13, Issue 3, 2016, Pages 461-470

  Billioux, Bridgette Jeanne ^a   Smith, Bryan ^a   Nath, Avindra ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

cognition; deafness; Ebola; encephalitis; insomnia; magnetic resonance imaging; meningitis; microvascular disease; vertigo

Indexed keywords

ANTIVIRUS AGENT; EBOLA VACCINE;

ACUTE DISEASE; ANTIVIRAL THERAPY; CLINICAL FEATURE; EBOLA HEMORRHAGIC FEVER; HUMAN; LABORATORY TEST; MORTALITY; NEUROLOGICAL COMPLICATION; NEUROPATHOLOGY; NONHUMAN; PERSISTENT VIRUS INFECTION; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; REVIEW; VACCINATION; VIROLOGY; VIRUS TRANSMISSION; BRAIN; COMPLICATION; CRANIAL NEUROPATHY; DISEASE TRANSMISSION; EPIDEMIC; HEADACHE; HEMORRHAGIC FEVER, EBOLA; MEMORY DISORDER; MENINGOENCEPHALITIS; NEUROLOGIC DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; SEIZURE; TREMOR;

BRAIN; CRANIAL NERVE DISEASES; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; HEADACHE; HEMORRHAGIC FEVER, EBOLA; HUMANS; MEMORY DISORDERS; MENINGOENCEPHALITIS; NERVOUS SYSTEM DISEASES; SEIZURES; TREMOR;

EID: 84978114927     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-016-0457-z     Document Type: Review

References (55)

1. Goeijenbier M, van Kampen JJ, Reusken CB, Koopmans MP, van Gorp EC. Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis. Neth J Med 2014;72:442-448.
2. Shears P, O'Dempsey TJ. Ebola virus disease in Africa: epidemiology and nosocomial transmission. J Hosp Infect 2015;90:1-9.
3. Luby JP, Sanders CV. Green monkey disease ("Marburg virus" disease): a new zoonosis. Ann Intern Med 1969;71:657-660.
4. World Health Organization. Ebola Situation Report 17 February 2016. Available from: http://apps.who.int/ebola/current-situation/ebola-situation-report-17-february-2016. Accessed February 19, 2016.
5. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses. J Pathol 2015;235:153-174.
6. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196(Suppl. 2):S142-S147.
7. Fischer WA, Uyeki TM, Tauxe RV. Ebola virus disease: What clinicians in the United States need to know. Am J Infect Control 2015;43:788-793.
8. Rewar S, Mirdha D. Transmission of ebola virus disease: an overview. Ann Glob Health 2014;80:444-451.
9. Klompas M, Yokoe DS. The Ebola transmission paradox. Am J Infect Control 2015;43:786-787.
10. Towner JS, Rollin PE, Bausch DG, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004;78:4330-4341.
11. Chertow DS, Kleine C, Edwards JK, Scaini R, Giuliani R, Sprecher A. Ebola virus disease in West Africa—clinical manifestations and management. N Engl J Med 2014;371:2054-2057.
12. Piercy TJ, Smither SJ, Steward JA, Eastaugh L, Lever MS. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 2010;109:1531-1539.
13. Brainard J, Hooper L, Pond K, Edmunds K, Hunter PR. Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis. Int J Epidemiol 2015;45:102-116.
14. Eggo RM, Watson CH, Camacho A, Kucharski AJ, Funk S, Edmunds WJ. Duration of Ebola virus RNA persistence in semen of survivors: population-level estimates and projections. Euro Surveill 2015;20(48).
15. Mate SE, Kugelman JR, Nyenswah TG, et al. molecular evidence of sexual transmission of Ebola virus. N Engl J Med 2015;373:2448-2454.
16. Singh G, Kumar A, Singh K, Kaur J. Ebola virus: an introduction and its pathology. Rev Med Virol 2015 Nov 12 [Epub ahead of print].
17. Schou S, Hansen AK. Marburg and Ebola virus infections in laboratory non-human primates: a literature review. Comp Med 2000;50:108-123.
18. West TE, von Saint André-von Arnim A. Clinical presentation and management of severe Ebola virus disease. Ann Am Thorac Soc 2014;11:1341-1350.
19. Gatherer D. The 2014 Ebola virus disease outbreak in West Africa. J Gen Virol 2014;95:1619-1624.
20. Fowler RA, Fletcher T, Fischer WA, et al. Caring for critically ill patients with ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 2014;190:733-737.
21. Khan AS, Tshioko FK, Heymann DL, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999;179(Suppl. 1):S76-S86.
22. Bwaka MA, Bonnet MJ, Calain P, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999;179(Suppl. 1):S1-S7.
23. Sagui E, Janvier F, Baize S, et al. severe ebola virus infection with encephalopathy: evidence for direct virus involvement. Clin Infect Dis 2015;61:1627-1628.
24. Howlett P, Brown C, Helderman T, et al. Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone. Emerg Infect Dis 2016;22:150-152.
25. Chertow DS, Nath A, Suffredini AF, et al. Severe meningoencephalitis in a case of Ebola virus disease. Ann Intern Med 2016 Apr 5 [Epub ahead of print].
26. Haddock LJ, Kim DY, Mukai S. Simple, inexpensive technique for high-quality smartphone fundus photography in human and animal eyes. J Ophthalmol 2013;2013:518479.
27. Kaushik A, Tiwari S, Dev Jayant R, Marty A, Nair M. Towards detection and diagnosis of Ebola virus disease at point-of-care. Biosens Bioelectron 2016;75:254-72.
28. Wauquier N, Becquart P, Padilla C, Baize S, Leroy EM. Human fatal Zaire Ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010;4.
29. Bechtelsheimer H, Korb G, Gedigk P. [The "Marburg-virus"-hepatitis. Studies in man and guinea pigs]. Virchows Arch A Pathol Pathol Anat 1970;351:273-290.
30. Slenczka WG. The Marburg virus outbreak of 1967 and subsequent episodes. Curr Top Microbiol Immunol 1999;235:49-75.
31. Larsen T, Stevens EL, Davis KJ, et al. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. J Infect Dis 2007;196(Suppl. 2):S323-S328.
32. de La Vega MA, Stein D, Kobinger GP. Ebolavirus evolution: past and present. PLoS Pathog 2015;11:e1005221.
33. Clark DV, Kibuuka H, Millard M, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis 2015;15:905-912
34. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999 179(Suppl 1):S28-S35.
35. Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis 2016;16:331-338.
36. Qureshi AI, Chughtai M, Loua TO, et al. Study of Ebola virus disease survivors in Guinea. Clin Infect Dis 2015;61:1035-1042.
37. Bowen L, Smith B, Steinbach S, Billioux BJ, et al. Survivors of Ebola virus disease have persistent neurologic deficits. 2016. Available from: https://www.aan.com/PressRoom/Home/GetDigitalAsset/12003 [abstract].
38. Rodriguez LL, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(Suppl. 1):S170-S176.
39. Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 1999;179(Suppl. 1):S13-S14.
40. Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 2014;371:2394-2401.
41. Lyon GM, Mehta AK, Varkey JB, et al. Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med 2014;371:2402-2409.
42. Deen GF, Knust B, Broutet N, et al. Ebola RNA persistence in semen of Ebola virus disease survivors – preliminary report. N Engl J Med 2015 Oct 14 [Epub ahead of print].
43. World Health Organization. Interim advice on the sexual transmission of the Ebola virus disease 21 January 2016. Available from: http://www.who.int/reproductivehealth/topics/rtis/ebola-virus-semen/en/. Accessed February 25, 2016.
44. Baggi FM, Taybi A, Kurth A, et al. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Euro Surveill 2014;19:pii: 20983.
45. Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 2015;372:2423-2427.
46. MacIntyre CR, Chughtai AA. Recurrence and reinfection – a new paradigm for the management of Ebola virus disease. Int J Infect Dis 2016;43:58-61.
47. Alves DA, Honko AN, Kortepeter MG, et al. Necrotizing scleritis, conjunctivitis, and other pathologic findings in the left eye and brain of an Ebola virus-infected rhesus macaque (Macaca mulatta) with apparent recovery and a delayed time of death. J Infect Dis 2016;213:57-60.
48. World Health Organization. Use of convalescent whole blood or plasma collected from patients recovered from Ebola virus disease for transfusion, as an empirical treatment during outbreaks—September 2014. Available from: http://www.searo.who.int/entity/emerging_diseases/ebola/who_his_sds_2014.8_eng.pdf. Accessed March 7, 2016.
49. van Griensven J, Edwards T, de Lamballerie X, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med 2016;374:33-42.
50. Davey R. PREVAIL II: a randomized controlled trial of ZMapp™ in acute Ebola virus infection [abstract]. In: Conference on Retroviruses and Opportunistic Infections; Feb 22–25, 2016; Boston, MA.
51. Sisoko D, Laouenan C, Folkesson E, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med 2016;13(3).
52. Ledgerwood JE, DeZure AD, Stanley DA, et al. Chimpanzee adenovirus vector Ebola vaccine – preliminary report. N Engl J Med 2014 Nov 26 [Epub ahead of print].
53. Henao-Restrepo AM, Longini IM, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 2015;386:857-866.
54. Bolay F. A randomized controlled trial of the safety and immunogenicity of two ebola vaccines. Presented in: Conference on Retroviruses and Opportunistic Infections; February 22–25, 2016; Boston, MA.
55. Fallah M, Dahn B, Nyenswah TG, et al. Interrupting Ebola transmission in Liberia through community-based initiatives. Ann Intern Med 2016;164:367-369.